mexiletine has been researched along with Cerebrovascular Disorders in 1 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edmondson, EA | 1 |
| Simpson, RK | 1 |
| Stubler, DK | 1 |
| Beric, A | 1 |
1 trial available for mexiletine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Systemic lidocaine therapy for poststroke pain.
Topics: Adult; Aged; Algorithms; Cerebrovascular Disorders; Drug Monitoring; Female; Follow-Up Studies; Huma | 1993 |